Antifibrinolytic amino acids for upper gastrointestinal bleeding in patients with acute or chronic liver disease.

Author: Martí-CarvajalArturo J, Martí-CarvajalPedro I, SolàIvan

Paper Details 
Original Abstract of the Article :
Upper gastrointestinal bleeding is one of the most frequent causes of morbidity and mortality in the course of liver cirrhosis. Patients with liver disease frequently have haemostatic abnormalities like hyperfibrinolysis. Therefore, antifibrinolytic amino acids have been proposed to be used as suppl...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/14651858.CD006007.pub3

データ提供:米国国立医学図書館(NLM)

Antifibrinolytic Amino Acids: A New Weapon Against Upper Gastrointestinal Bleeding in Liver Disease

The world of [liver disease] is filled with challenges, and [upper gastrointestinal bleeding] is one of the most pressing concerns. This research explores the potential of [antifibrinolytic amino acids] in managing this complication, particularly in patients with [acute or chronic liver disease]. It's like exploring a desert for resources, seeking ways to address the challenges faced by those with liver disease.

Fibrinolysis and Liver Disease: A Delicate Balance

The authors highlight the crucial role of [fibrinolysis] in the context of liver disease. Think of fibrinolysis as a careful dance, where the balance between blood clotting and dissolving clots is essential. In liver disease, this delicate balance can be disrupted, leading to excessive fibrinolysis, a situation like a desert experiencing an unexpected flood. The study proposes that [antifibrinolytic amino acids] could be used alongside primary treatments for upper gastrointestinal bleeding, providing a potential lifeline for patients navigating these challenging conditions.

A Potential Boon for Liver Disease Management

This research offers a glimpse into a potential new approach for managing [upper gastrointestinal bleeding] in [liver disease]. While further investigation is needed to fully understand the efficacy and safety of [antifibrinolytic amino acids] in this context, the study highlights a promising avenue for improving patient outcomes. It's like finding a hidden spring in the desert, providing a potential source of relief and hope for those battling liver disease.

Dr.Camel's Conclusion

The study of [antifibrinolytic amino acids] in the context of [upper gastrointestinal bleeding] in [liver disease] highlights the importance of exploring new avenues for treatment. It's a reminder that the vast desert of medical research often holds hidden treasures waiting to be discovered, offering potential solutions to challenging health conditions.

Date :
  1. Date Completed 2012-10-30
  2. Date Revised 2018-12-21
Further Info :

Pubmed ID

22972089

DOI: Digital Object Identifier

10.1002/14651858.CD006007.pub3

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.